BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3984305)

  • 1. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator.
    Steeper TA; Smith JA; McCullough J
    Vox Sang; 1985; 48(4):193-200. PubMed ID: 3984305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation of therapeutic doses of leukocytes and thrombocytes using a blood cell separator].
    Bláha M; Vanasek J; Malý J; Siroký O; Pecka M
    Gematol Transfuziol; 1983 Oct; 28(10):23-5. PubMed ID: 6654008
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of thrombocyte concentrates of the cell separator AS 104 with preparations of the cell separator CS 3000 (Fenwal)].
    Aulmann HM; Müller R; Zaky M; Avenarius HJ; Stangel W
    Beitr Infusionsther; 1990; 26():127-30. PubMed ID: 1703811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the CS-3000 Cell Separator (Fenwal) for therapeutic lymphocyte depletion in thrombocytopenic patients with chronic lymphatic leukemia (CLL)].
    Brauer H; Aulmann HM; Wassmann A; Stangel W; Le Blanc S; Diedrich H; Meinicke K; Poliwoda H
    Beitr Infusionther Klin Ernahr; 1987; 18():230-3. PubMed ID: 3439980
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of thrombocytosis by plateletpheresis using a cell separator.
    Beard ME; Blacklock HA; Varcoe AR
    N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donors leukapheresis on Fenwal CS-3000.
    Kotelba-Witkowska B; Mrowiec ZR; Daszyński J; Skrzeczkowska E
    Mater Med Pol; 1990; 22(1):33-5. PubMed ID: 2079859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plateletpheresis experience with the Haemonetics Blood Processor 30, the IBM Blood Processor 2997, and the Fenwal CS-3000 Blood Processor.
    Kurtz SR; McMican A; Carciero R; Melaragno A; Abdu W; Katchis R; Valeri CR
    Vox Sang; 1981; 41(4):212-8. PubMed ID: 7336674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative function of centrifugal apheresis devices.
    Rock G; Blanchette V; McCombie N; Tittley P
    Vox Sang; 1985; 48(3):136-42. PubMed ID: 3984299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effect of Cobe Spectra and Fenwal CS 3000 plus blood cell separators in collection of peripheral blood stem cell components].
    Yang SM; Liu KY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):245-9. PubMed ID: 15854285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Fenwal CS-3000 plateletpheresis performed at a rapid donor blood flow rate: rapid plateletpheresis with Fenwal CS-3000.
    Strauss RG; Ludwig GA; Randels MJ; Winegarden DC
    J Clin Apher; 1991; 6(1):21-3. PubMed ID: 2045378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
    Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
    Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the Fenwal CS-3000 automatic blood cell separator for cytopheresis (review)].
    Fiala J
    Vnitr Lek; 1986 Feb; 32(2):173-9. PubMed ID: 3962198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the centrifugation speed on the sedimentation behavior of thrombocytes in the CS-3000 Cell Separator (Fenwal)].
    Brauer H; Aulmann HM; Stangel W
    Beitr Infusionther Klin Ernahr; 1987; 18():219-22. PubMed ID: 3439977
    [No Abstract]   [Full Text] [Related]  

  • 14. [The safety of apparative cytapheresis].
    Böhm R; Borberg H
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():18-27. PubMed ID: 3679527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side-effects of cytapheresis with cell separators.
    Höcker P; Wagner A
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():31-5. PubMed ID: 3679528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications and limitations of hemapheresis.
    Silvergleid AJ
    Annu Rev Med; 1983; 34():69-89. PubMed ID: 6344778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
    Wassmann A; Aulmann HM; Stangel W; Meinicke K
    Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic plasma and cellular apheresis.
    Urbaniak SJ
    Clin Haematol; 1984 Feb; 13(1):217-51. PubMed ID: 6373082
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukapheresis: increasing the granulocyte yield with the Fenwal CS-3000.
    Loftus TJ; White RF; Huestis DW
    J Clin Apher; 1983; 1(2):109-14. PubMed ID: 6681481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytapheresis: the first 25 years.
    Isbister JP
    Ther Apher; 1997 Feb; 1(1):17-21. PubMed ID: 10225775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.